Momenta Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Momenta Pharmaceuticals

Access the complete profile.

Momenta Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	301 Binney Street Cambridge, MA 02142

Momenta Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Momenta Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Momenta Pharmaceuticals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Momenta Pharmaceuticals is a publicly traded company on NMS using the ticker symbol MNTA. Detailed information on company financials and operating reports can be found here: NMS: MNTA

Momenta Pharmaceuticals Annual Revenue and Growth Rate

Momenta Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Momenta Pharmaceuticals's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Momenta Pharmaceuticals is developing and marketing. Momenta Pharmaceuticals doesn't have any recent trademark applications, indicating Momenta Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
STATUEBIO Reagents for scientific and medical research	08/13/2018
STATUE Reagents for scientific and medical research	07/12/2018

See all trademarks and details in the Full Report.

Market Share of Momenta Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Momenta Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Momenta Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Other Companies at 301 Binney Street, Cambridge MA

Company	Headquarters	Revenue ($ MM)
GENERATION BIO	Cambridge, MA	100
IRONWOOD PHARMACEUTICALS	Cambridge, MA	37
CYCLERION THERAPEUTICS	Cambridge, MA	6
LIVING PROOF	Cambridge, MA	4

Future Competition: Momenta Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Momenta Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)